Fact CheckerSign in

NCT06915831Recruiting

Type 1 Diabetes and Obstructive Sleep Apnea

Obstructive Sleep Apnea and Glycemic Dysregulation in Adults With Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 20 Jan 2026

Brief summary (registry, in English)

The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
31 Mar 2025
Start date
10 Nov 2025
Primary completion date
31 Aug 2029
Lead sponsor
University of Chicago
NCT number
NCT06915831

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 10 Nov 2025 to the primary completion date, 31 Aug 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent major surgery
  • Subjects will also be excluded if taking medications that can confound metabolic assessments including systemic glucocorticoids, antipsychotics, thiazide diuretics, beta-blockers, daily use of aminophylline or theophylline, or use of any immunosuppressant.
  • Smoking, alcohol or illegal drug abuse

Other illness

  • Acute coronary syndrome or stroke past 6 months
  • Severe hypertension (blood pressure\>180/105 mmHg)
  • Any other significant health condition: unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class\>2, pulmonary disease with dependence on oxygen or daily use of bronchodilators, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly)
  • Major psychiatric disorder

Lab values

  • ≥1 trip to emergency room for poor glucose management in the past 6 months
  • Liver transaminases \>2 times upper limit of normal,
  • Renal transplantation or serum creatinine \>1.5 mg/dL
  • Anemia (hemoglobin \<13.0g/dL in men or \<11.6g/dL in women)

Other

  • Regular and adherent CPAP use per clinical guidelines
  • Requiring oxygen or advanced positive airway pressure modalities during sleep
  • Having a 'fall-asleep' or 'near miss' accident in the past 6-months
  • Shift work
  • Severe hypoglycemia (≥1 episode in the past 3 months or diagnosis of hypoglycemic unawareness)
  • Proliferative retinopathy
  • Fasting triglycerides \>400mg/dL,
  • Currently pregnant or trying to get pregnant or nursing

Who the study is looking for

  • Age: 18 to 50 years old
  • Type 1 Diabetes on insulin pump therapy and using a CGM device with an GMI (glucose management indicator) between 5.5 and 8.5% with hemoglobin in the normal range at screening
  • OSA by home sleep apnea test

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.